Dr. Robert L. Randall, MD
Orthopedic Surgery (Orthopaedic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Yale University School of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 115
Licensed in California since 1994, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: Yale University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Orthopaedic Surgery Physician primary
CA license G78312 (first issued 1994; current) · UT license 360087-1205 -
Surgical Oncology Physician
CA license G78312 (first issued 1994; current) · UT license 360087-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of California Davis Medical Center Sacramento, CA
- Glendale Adventist Medical Center Glendale, CA
Medical groups
- Regents of the Univ of Ca (1,584 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 115
- Services billed
- 165
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 49 | 39 |
| Established patient office or other outpatient visit, 30-39 minutes | 22 | 20 |
| New patient office or other outpatient visit, 30-44 minutes | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 41 payments worth $36,710 in total to this clinician.
| Springworks Therapeutics, Inc. | $17,890 |
|---|---|
| Zimmer Biomet Holdings, Inc. | $14,584 |
| Deciphera Pharmaceuticals Inc. | $3,236 |
| Signature Orthopaedics USA Corp | $1,000 |
| Compensation for services other than consulting (speaking, faculty) | $15,713 |
|---|---|
| Education | $12,750 |
| Consulting Fee | $3,625 |
| Honoraria | $2,340 |
| Travel and Lodging | $1,463 |
| Food and Beverage | $673 |
| Gift | $146 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Springworks Therapeutics, Inc. Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,925 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $4,750 |
| Springworks Therapeutics, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $3,938 |
| Springworks Therapeutics, Inc. Jul 10, 2025 | Consulting Fee OGSIVEO · DESMOID TUMORS | $2,625 |
| Deciphera Pharmaceuticals Inc. Mar 17, 2025 | Honoraria VIMSELTINIB · ONCOLOGY | $2,340 |
| Zimmer Biomet Holdings, Inc. Dec 30, 2025 | Education OSS Orthopedic Salvage System · Knees | $2,000 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $2,000 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education Arcos; G7 · Hips | $1,750 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $1,625 |
| Springworks Therapeutics, Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,050 |
All 30 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Signature Orthopaedics USA Corp Dec 31, 2025 | Consulting Fee | $1,000 |
| Zimmer Biomet Holdings, Inc. Dec 30, 2025 | Education OSS Orthopedic Salvage System · Knees | $2,000 |
| Zimmer Biomet Holdings, Inc. Dec 30, 2025 | Education OSS Orthopedic Salvage System · Knees | $625 |
| Deciphera Pharmaceuticals Inc. Dec 4, 2025 | Gift in-kind | $69.74 |
| Deciphera Pharmaceuticals Inc. Nov 13, 2025 | Gift QINLOCK · ONCOLOGY · in-kind | $76.40 |
| Springworks Therapeutics, Inc. Sep 4, 2025 | Travel and Lodging travel to POIPU, HI | $105 |
| Springworks Therapeutics, Inc. Sep 4, 2025 | Travel and Lodging travel to POIPU, HI | $72.37 |
| Springworks Therapeutics, Inc. Sep 4, 2025 | Travel and Lodging travel to POIPU, HI | $11.69 |
| Springworks Therapeutics, Inc. Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) | $8,925 |
| Deciphera Pharmaceuticals Inc. Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) ROMVIMZA · ONCOLOGY | $750 |
| Springworks Therapeutics, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $3,938 |
| Springworks Therapeutics, Inc. Jul 17, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $1,050 |
| Springworks Therapeutics, Inc. Jul 10, 2025 | Consulting Fee OGSIVEO · DESMOID TUMORS | $2,625 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $4,750 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $2,000 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education Arcos; G7 · Hips | $1,750 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Education G7; Arcos · Hips | $1,625 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Travel and Lodging Arcos; G7 · Hips · travel to Los Angeles, CA | $43.68 |
| Zimmer Biomet Holdings, Inc. May 23, 2025 | Travel and Lodging Arcos; G7 · Hips · travel to Los Angeles, CA | $37.82 |
| Zimmer Biomet Holdings, Inc. May 3, 2025 | Travel and Lodging travel to Carson, CA · in-kind | $160 |
| Zimmer Biomet Holdings, Inc. May 3, 2025 | Travel and Lodging travel to Fort Worth, TX · in-kind | $35.00 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $359 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Overland Park, KS · in-kind | $234 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Los Angeles, CA · in-kind | $178 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Carson, CA · in-kind | $165 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Overland Park, KS · in-kind | $35.00 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Los Angeles, CA · in-kind | $25.00 |
| Zimmer Biomet Holdings, Inc. May 2, 2025 | Travel and Lodging travel to Overland Park, KS · in-kind | $0.36 |
| Springworks Therapeutics, Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,050 |
| Deciphera Pharmaceuticals Inc. Mar 17, 2025 | Honoraria VIMSELTINIB · ONCOLOGY | $2,340 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $16,790 in research payments for these studies, mostly to the institutions running them.
- Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Deciphera Pharmaceuticals Inc. · Active, not recruiting · NCT03069469
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.